Table 2 Summary of systemic AL amyloidosis patients (n = 575) included in subset analyses.

From: Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients

  

Median (IQR) values at sample collection

Description of subgroup

Number of patients

uACR (mg/g)

24hUP (mg)

dFLC (mg/L)

eGFR—(mL/min/1.73 m2)

Paired uACR and 24hUP samples <30 days from diagnosisa

155

1362 (87–4311)

1469 (286–5208)

242 (89–625)

62 (39–78)

Renal involvement at diagnosis

109

3329 (1149–5151)

3176 (1307–7823)

174 (70–491)

63 (38–78)

eGFR <30 mL/min/1.73 m2 at sample collection

127

2146 (334–5859)

2663 (654–5996)

31 (11–169)

18 (11–25)

24hUP < 3000 mg/day at sample collection

466

78 (12–743)

244 (124–1119)

27 (8–140)

59 (39–75)

≥2 paired uACR and 24hUP samples in patients with renal involvement at diagnosisa

224

959 (134–2560)b

1211 (279–3994)b

18 (5–72)b

52 (28–71)b

uACR, uPCR, and 24hUP available during disease follow-up

286

730 (33–3830)

1054 (180–4226)

61 (13–278)

51 (26–73)

  1. aPaired uACR and 24hUP samples were collected a maximum of 7 days apart, and paired uPCR samples were included if a urinalysis was collected on the same day as the uACR.
  2. bLaboratory values at the time of the first uACR collection are presented in this table.
Back to article page